iBio, Inc. (IBIO) Receives NHLB Grant for Further Development of Fibrotic Diseases Treatments
Tweet Send to a Friend
iBio, Inc. (NYSE: IBIO) announced the award of a grant to fund further development of its proprietary therapeutic product for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
